Inducing autophagy is becoming a popular strategy as targeting chimeras extend beyond protein degradation.

By Danielle Golovin, Staff Writer Aug 20, 2021 | 5:13 PM GMT

On August 21, TAC development-related company selected company 4 to develop a new autophage-centered platform at Biocentury in the United States.

Among them, Autotech Bio was mentioned as a representative company.

For details, please refer to the link below.